Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology

Background. Diabetic nephropathy (DN), characterized by hyperglycemia, hypertension, proteinuria, and edema, is a unique microvascular complication of diabetes. Traditional Chinese medicine (TCM) Astragalus membranaceus (AM) has been widely used for DN in China while the pharmacological mechanisms a...

Full description

Bibliographic Details
Main Authors: Ming-Fei Guo, Ya-Ji Dai, Jia-Rong Gao, Pei-Jie Chen
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/5947304
id doaj-d1e40deb9f514c5cb6d4c9bebce4cbd8
record_format Article
spelling doaj-d1e40deb9f514c5cb6d4c9bebce4cbd82020-11-25T02:10:33ZengHindawi LimitedJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/59473045947304Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network PharmacologyMing-Fei Guo0Ya-Ji Dai1Jia-Rong Gao2Pei-Jie Chen3Department of Pharmacy, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230012, ChinaDepartment of Pharmacy, Anhui No.2 Provincial People’s Hospital, Hefei, Anhui 230041, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui 230031, ChinaDepartment of Pharmacy, The Fourth Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230012, ChinaBackground. Diabetic nephropathy (DN), characterized by hyperglycemia, hypertension, proteinuria, and edema, is a unique microvascular complication of diabetes. Traditional Chinese medicine (TCM) Astragalus membranaceus (AM) has been widely used for DN in China while the pharmacological mechanisms are still unclear. This work is aimed at undertaking a network pharmacology analysis to reveal the mechanism of the effects of AM in DN. Materials and Methods. In this study, chemical constituents of AM were obtained via Traditional Chinese Medicine Systems Pharmacology Database (TCMSP), and the potential targets of AM were identified using the Therapeutic Target Database (TTD). DisGeNET and GeneCards databases were used to collect DN-related target genes. DN-AM common target protein interaction network was established by using the STRING database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were carried out to further explore the DN mechanism and therapeutic effect of AM. The network diagrams of the active component-action target and protein-protein interaction (PPI) networks were constructed using Cytoscape software. Results. A total of 16 active ingredients contained and 78 putative identified target genes were screened from AM, of which 42 overlapped with the targets of DN and were considered potential therapeutic targets. The analysis of the network results showed that the AM activity of component quercetin, formononetin, calycosin, 7-O-methylisomucronulatol, and quercetin have a good binding activity with top ten screened targets, such as VEGFA, TNF, IL-6, MAPK, CCL3, NOS3, PTGS2, IL-1β, JUN, and EGFR. GO and KEGG analyses revealed that these targets were associated with inflammatory response, angiogenesis, oxidative stress reaction, rheumatoid arthritis, and other biological process. Conclusions. This study demonstrated the multicomponent, multitarget, and multichannel characteristics of AM, which provided a novel approach for further research of the mechanism of AM in the treatment of DN.http://dx.doi.org/10.1155/2020/5947304
collection DOAJ
language English
format Article
sources DOAJ
author Ming-Fei Guo
Ya-Ji Dai
Jia-Rong Gao
Pei-Jie Chen
spellingShingle Ming-Fei Guo
Ya-Ji Dai
Jia-Rong Gao
Pei-Jie Chen
Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
Journal of Diabetes Research
author_facet Ming-Fei Guo
Ya-Ji Dai
Jia-Rong Gao
Pei-Jie Chen
author_sort Ming-Fei Guo
title Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
title_short Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
title_full Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
title_fullStr Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
title_full_unstemmed Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology
title_sort uncovering the mechanism of astragalus membranaceus in the treatment of diabetic nephropathy based on network pharmacology
publisher Hindawi Limited
series Journal of Diabetes Research
issn 2314-6745
2314-6753
publishDate 2020-01-01
description Background. Diabetic nephropathy (DN), characterized by hyperglycemia, hypertension, proteinuria, and edema, is a unique microvascular complication of diabetes. Traditional Chinese medicine (TCM) Astragalus membranaceus (AM) has been widely used for DN in China while the pharmacological mechanisms are still unclear. This work is aimed at undertaking a network pharmacology analysis to reveal the mechanism of the effects of AM in DN. Materials and Methods. In this study, chemical constituents of AM were obtained via Traditional Chinese Medicine Systems Pharmacology Database (TCMSP), and the potential targets of AM were identified using the Therapeutic Target Database (TTD). DisGeNET and GeneCards databases were used to collect DN-related target genes. DN-AM common target protein interaction network was established by using the STRING database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were carried out to further explore the DN mechanism and therapeutic effect of AM. The network diagrams of the active component-action target and protein-protein interaction (PPI) networks were constructed using Cytoscape software. Results. A total of 16 active ingredients contained and 78 putative identified target genes were screened from AM, of which 42 overlapped with the targets of DN and were considered potential therapeutic targets. The analysis of the network results showed that the AM activity of component quercetin, formononetin, calycosin, 7-O-methylisomucronulatol, and quercetin have a good binding activity with top ten screened targets, such as VEGFA, TNF, IL-6, MAPK, CCL3, NOS3, PTGS2, IL-1β, JUN, and EGFR. GO and KEGG analyses revealed that these targets were associated with inflammatory response, angiogenesis, oxidative stress reaction, rheumatoid arthritis, and other biological process. Conclusions. This study demonstrated the multicomponent, multitarget, and multichannel characteristics of AM, which provided a novel approach for further research of the mechanism of AM in the treatment of DN.
url http://dx.doi.org/10.1155/2020/5947304
work_keys_str_mv AT mingfeiguo uncoveringthemechanismofastragalusmembranaceusinthetreatmentofdiabeticnephropathybasedonnetworkpharmacology
AT yajidai uncoveringthemechanismofastragalusmembranaceusinthetreatmentofdiabeticnephropathybasedonnetworkpharmacology
AT jiaronggao uncoveringthemechanismofastragalusmembranaceusinthetreatmentofdiabeticnephropathybasedonnetworkpharmacology
AT peijiechen uncoveringthemechanismofastragalusmembranaceusinthetreatmentofdiabeticnephropathybasedonnetworkpharmacology
_version_ 1715554801302896640